I believe [Rick Shea] said something along the lines that it's harder to partner [M118] because the number of potential partners is more limited now.
That’s old hat (Shea and Wheeler have said it many times) and it’s simply common sense.
Look at the compilation in #msg-53212303 and you’ll see how many Big Pharma are already committed to large and expensive development programs for anticoagulants:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.